KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $3.4 million.

  • Medpace Holdings' Cash from Financing Activities fell 4560.09% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 662314.09%. This contributed to the annual value of -$154.0 million for FY2024, which is 1567.71% up from last year.
  • Latest data reveals that Medpace Holdings reported Cash from Financing Activities of $3.4 million as of Q3 2025, which was down 4560.09% from -$540.6 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Cash from Financing Activities high stood at $9.1 million for Q1 2021, and its period low was -$540.6 million during Q2 2025.
  • Its 5-year average for Cash from Financing Activities is -$107.4 million, with a median of -$50.8 million in 2021.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 12250.46% in 2021, then crashed by 8126576.58% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Cash from Financing Activities stood at $2.4 million in 2021, then crashed by 5493.71% to -$131.1 million in 2022, then skyrocketed by 101.16% to $1.5 million in 2023, then plummeted by 11170.85% to -$168.6 million in 2024, then skyrocketed by 102.02% to $3.4 million in 2025.
  • Its Cash from Financing Activities stands at $3.4 million for Q3 2025, versus -$540.6 million for Q2 2025 and -$346.0 million for Q1 2025.